ATLAS / Macro Radar / Reporting / NGNE

Neurogene Inc. (NGNE) reporting calendar

Neurogene Inc. files periodic reports with the SEC as NGNE on Nasdaq. Atlas tracks 49 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 3 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
12 May 2026
Reports on record
49

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 43 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open NGNE market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202612 May 202642 days0001404644-26-000037
10-K31 Dec 202524 Mar 202683 days0001404644-26-000019
10-Q30 Sep 202513 Nov 202544 days0001404644-25-000101
10-Q30 Jun 202511 Aug 202542 days0001404644-25-000081
10-Q31 Mar 20259 May 202539 days0001404644-25-000041
10-K31 Dec 202424 Mar 202583 days0001404644-25-000012
10-Q30 Sep 202418 Nov 202449 days0001404644-24-000104
10-Q30 Jun 20249 Aug 202440 days0001404644-24-000086
10-Q31 Mar 202410 May 202440 days0001404644-24-000057
10-K31 Dec 202318 Mar 202478 days0001404644-24-000020
10-Q30 Sep 202314 Nov 202345 days0001628280-23-038797
10-Q30 Jun 202310 Aug 202341 days0001628280-23-028856
10-Q31 Mar 20238 May 202338 days0001628280-23-016425
10-K31 Dec 202220 Mar 202379 days0001628280-23-008602
10-Q30 Sep 202214 Nov 202245 days0001628280-22-029833
10-Q30 Jun 20229 Aug 202240 days0001628280-22-021923
10-Q31 Mar 20229 May 202239 days0001628280-22-013306
10-K31 Dec 20211 Mar 202260 days0001628280-22-004491
10-Q30 Sep 20214 Nov 202135 days0001628280-21-021773
10-Q30 Jun 20215 Aug 202136 days0001628280-21-015861
10-Q31 Mar 202112 May 202142 days0001628280-21-009912
10-K31 Dec 202025 Mar 202184 days0001628280-21-005630
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052218
10-Q30 Jun 202012 Aug 202043 days0001564590-20-039671
10-Q31 Mar 20206 May 202036 days0001564590-20-021920
10-K31 Dec 201912 Mar 202072 days0001193125-20-071545
10-Q30 Sep 201913 Nov 201944 days0001193125-19-290610
10-Q30 Jun 20191 Aug 201932 days0001193125-19-209916
10-Q31 Mar 20197 May 201937 days0001193125-19-139021
10-K31 Dec 20187 Mar 201966 days0001193125-19-066506
10-Q30 Sep 20187 Nov 201838 days0001193125-18-320293
10-Q30 Jun 20188 Aug 201839 days0001193125-18-242081
10-Q31 Mar 20188 May 201838 days0001193125-18-155359
10-K31 Dec 201712 Mar 201871 days0001193125-18-079210
10-Q30 Sep 20178 Nov 201739 days0001193125-17-336565
10-Q30 Jun 20178 Aug 201739 days0001193125-17-250714
10-Q31 Mar 20179 May 201739 days0001193125-17-163318
10-K31 Dec 20169 Mar 201768 days0001193125-17-076939
10-Q30 Sep 20169 Nov 201640 days0001193125-16-763805
10-Q30 Jun 20164 Aug 201635 days0001193125-16-671769

Source: SEC EDGAR company submissions for CIK 0001404644. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.